Skip to Content

ASCO 2009

The Annual Meeting of the American Society of Clinical Oncology (ASCO) is taking place in Orlando, USA from May 29 to June 2, 2009. Roche as a leader in Oncology has a great presence at the conference with more than 500 scientific abstracts across twenty different types of cancer.

Here you will find the latest Roche news from the conference as well as supporting information about the ASCO sessions and press activities.

Latest News from ASCO
TitleDownload
Media Release June 01, 2009: Encouraging first data on new targeted treatment for patients with melanoma – the deadliest form of skin cancer more...PDF
Media Release May 31, 2009: Herceptin landmark study (ToGA) reveals unprecedented survival benefit in HER2-positive stomach cancer more...PDF
Media Release May 30, 2009: Maintenance treatment with Avastin and Tarceva in combination helps lung cancer patients live longer without their disease worsening more...PDF
Media Release May 30, 2009: Full results from first Phase III study of Avastin in adjuvant colon cancer announced more...PDF
Trade News May 29, 2009: Avastin plus commonly used chemotherapies improves the time breast cancer patients live without their disease getting worse more...
Trade News May 28, 2009: New form of targeted therapy offers further hope to patients with advanced HER2-positive breast cancer more...
Media Release May 15, 2009: Roche to present major advances with targeted cancer medicines at ASCO more...PDF
Roche Media Events at ASCO
Briefing for non-US media, Friday 29 May, 09:00-10:45 (EDT)PDF
Briefing for Asian media, Saturday 30 May, 06:30-07:25 (EDT)PDF
Briefing on PLX4032/R7204 for US and non-US media, Monday 1 June, 06:30-07:45 (EDT)PDF
Background Information
About Roche in oncologyPDF
Breast cancer backgrounderPDF
Cancer - a major global health challengePDF
Cancer facts backgrounderPDF
Chronic Lymphocytic Leukemia backgrounderPDF
Colorectal cancer backgrounderPDF
Non Small Cell Lung Cancer backgrounderPDF
Roche in Oncology backgrounderPDF
Roche Oncology R&DPDF (2.7 MB)